Ventana Medical Systems
Global diagnostics organization providing in vitro diagnostic instruments, assays, reagents and digital solutions across clinical chemistry, immunoassays, molecular diagnostics, pathology and point-of-care testing. Operates laboratory automation and sample-to-answer workflows, develops and validates clinical biomarkers and diagnostic assays, provides instrument service and lifecycle support, and publishes clinical and implementation insights and educational content.
Industries
Nr. of Employees
Very Large (1000+)
Ventana Medical Systems
Patents
Synthesis singleplex from multiplex brightfield imaging using generative adversarial network
US-12731250-B2
View Details
Synthesis singleplex from multiplex brightfield imaging using generative adversarial network
US-12731250-B2
View DetailsProducts
Automated molecular diagnostic systems
Laboratory systems that provide automated PCR-based nucleic acid testing and integrated sample-to-answer workflows for clinical molecular diagnostics.
qPCR amplification platforms for research and clinical use
Quantitative PCR platforms intended for research and diagnostic applications that provide configurable assay support and accurate quantitation.
Integrated clinical chemistry and immunoassay systems
Modular systems that combine clinical chemistry, immunoassay and related testing on compact footprints for core and mid-volume laboratories.
Point-of-care molecular and immunoassay analyzers
Near‑patient testing systems for rapid molecular and immunoassay diagnostics designed for use outside central laboratories.
Sequencing probes and library preparation kits
Probe sets and library kits for whole exome and RNA sequencing workflows used in research and translational applications.
Digital pathology scanners and automated staining systems
Whole‑slide scanners and fully automated staining systems to support digital pathology workflows and slide digitization.
Automated molecular diagnostic systems
Laboratory systems that provide automated PCR-based nucleic acid testing and integrated sample-to-answer workflows for clinical molecular diagnostics.
qPCR amplification platforms for research and clinical use
Quantitative PCR platforms intended for research and diagnostic applications that provide configurable assay support and accurate quantitation.
Integrated clinical chemistry and immunoassay systems
Modular systems that combine clinical chemistry, immunoassay and related testing on compact footprints for core and mid-volume laboratories.
Point-of-care molecular and immunoassay analyzers
Near‑patient testing systems for rapid molecular and immunoassay diagnostics designed for use outside central laboratories.
Sequencing probes and library preparation kits
Probe sets and library kits for whole exome and RNA sequencing workflows used in research and translational applications.
Digital pathology scanners and automated staining systems
Whole‑slide scanners and fully automated staining systems to support digital pathology workflows and slide digitization.
Services
Customer service, maintenance and lifecycle programs supporting laboratory instruments and automated workflows to sustain instrument uptime and operational performance.
Customer service, maintenance and lifecycle programs supporting laboratory instruments and automated workflows to sustain instrument uptime and operational performance.
Expertise Areas
- Clinical diagnostics across multiple modalities
- Molecular diagnostics and nucleic acid amplification testing
- Point-of-care testing and near-patient diagnostics
- Laboratory automation and workflow integration
Key Technologies
- Real-time PCR and qPCR
- Sample-to-answer automation
- Next-generation sequencing (including sequencing-by-expansion methods)
- Automated clinical mass spectrometry
News & Updates
Event listing highlighting participation and content about transforming the cardiac care continuum from early diagnosis to monitoring.
Discussion of how advances in mass spectrometry, particularly automated workflows, are transforming diagnostics in clinical laboratories.
Overview of a sequencing-by-expansion approach to next-generation sequencing and its potential to support ultra-rapid sequencing and multi-omics integration.
Description of integrated sequencing analysis tools providing real-time base calling and mapping to accelerate high-throughput sequencing results.
Summary of a global diagnostic study program validating a high-sensitivity troponin assay and establishing new benchmarks for AMI diagnosis.
Description of a collaborative biomarker ecosystem to accelerate diagnostic validation for Alzheimer’s and neurological disorders.
Event listing highlighting participation and content about transforming the cardiac care continuum from early diagnosis to monitoring.
Discussion of how advances in mass spectrometry, particularly automated workflows, are transforming diagnostics in clinical laboratories.
Overview of a sequencing-by-expansion approach to next-generation sequencing and its potential to support ultra-rapid sequencing and multi-omics integration.
Description of integrated sequencing analysis tools providing real-time base calling and mapping to accelerate high-throughput sequencing results.
Summary of a global diagnostic study program validating a high-sensitivity troponin assay and establishing new benchmarks for AMI diagnosis.
Description of a collaborative biomarker ecosystem to accelerate diagnostic validation for Alzheimer’s and neurological disorders.